August 28th 2023
With an increased incidence of this sexually transmitted infection, a review of an older antibiotic for treatment has shown some clinical benefits in other countries.
July 31st 2023
The vaccine has been approved since late 2019 for adults age 18 and older.
July 26th 2023
The phase 1/2 trial evaluating EBT-101 dosed its first patient in September 2022.
The update refreshes the organization's 2022 guidance on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations, focusing on people in prisons and other closed settings.
April 7th 2023
When taken within 3 days, doxycycline given post-exposure (doxy-PEP) decreased the incidence rates of syphilis, gonorrhea, and chlamydia significantly.
Inadequate HIV Testing of Children Across 7 African Nations
The first study to estimate rates of undiagnosed HIV in children across sub-Saharan Africa found significant gaps in HIV testing.
HIV PrEP Access May Be Limited by States’ Prescriber Laws
States that required ongoing medical doctor supervision of nurse practitioners and physician assistants had fewer HIV PrEP prescriptions.
Moderna, IAVI Testing mRNA Technology for HIV Vaccine
Researchers could be one step closer to an HIV vaccine. This one uses mRNA technology.
Model that Decriminalized Drugs, Invests Savings Shows Reduction in HIV Transmission
The study authors focused on eastern Europe and central Asia in their model, which included 4 scenarios for decriminalizing drug use and investing the savings into HIV transmission-reduction strategies.
Age, Sex Factors for Heart Failure Among HIV Patients
Providers of patients with HIV should have greater sensitivity to symptoms of heart failure, the study authors suggested.
HIV Preventative Strategies Reduce Orphanhood in Adolescents
The study authors observed reductions in three types of orphanhood, including paternal-only, maternal-only, and double orphanhood.
Ending the HIV Epidemic Initiative: Can We Get There?
In utilizing a modeling study, investigators estimated reductions in HIV incidence rates as well as PrEP usage rates and viral suppression across US cities over 10 years.
How Engaged in HIV Care are Pregnant Women?
There is a high level of engagement in HIV care observed among pregnant women, which displays a commitment to their health and wellbeing during their pregnancy, the study authors wrote.
Minority MSM Groups Need Increased Access to HIV Services
By 2030, the US is targeting reducing the number of new HIV infections by 90 percent.
Dolutegravir-Based Treatment More Effective in Children Living With HIV
Dolutegravir-based antiretroviral therapy proved more effective than standard treatments for HIV-positive children, reducing treatment failure by 40%.
One-Stop Shop Model Benefits PrEP Delivery
Investigators compared pre- and post-intervention data points at 4 clinics in Kenya.
Although PrEP is Largely Underutilized, Developing Strategies Aim to Increase Initiation
Stigma, and a lack of communication and awareness all inhibit HIV PrEP uptake, but digital health and new forms of PrEP are aiming to increase users.
FDA Approves Injectable Cabotegravir for PrEP
The therapy becomes the first injectable approved in the United States for this indication.
Federal Appropriations Bill is Marked for HIV, PrEP Spending
The proposed funding will include a number of measures of spending towards HIV and prevention, including community centers for PrEP education.
Salience Bias in Childhood HPV Vaccination Decisions
A personal history of cervical cancer or cervical biopsy did not make mothers more likely to vaccinate their children against HPV.
Digital Pill Accurately Tracks HIV PrEP Adherence
A novel digital pill was 98% effective in tracking daily HIV PrEP adherence.
Vaccination Against HPV Decreases Cervical Cancer, Especially in Young Women
HPV vaccination decreases cervical cancer incidence and mortality, but it is most effective in young women and girls.
Community HIV Care as Effective as Facility-Based Care
Community-based models of antiretroviral therapy were as effective as facility-based care in terms of viral suppression, the study authors wrote.
CDC Updates Guidelines: Doctors Should Talk to All Sexually Active People About HIV PrEP
The CDC updated its HIV PrEP guidelines, including a recommendation that doctors talk to all sexually active adults about HIV prevention and prescribe PrEP to anyone who asks for it.
Merck Pauses Enrollment in Phase 3 Clinical Trials for Islatravir HIV PrEP
Merck announced an enrollment pause in 2 of their stage 3 clinical trials for once-monthly oral islatravir for HIV PrEP. Enrolled participants will continue receiving study medicine.
Meth Use and Partner Violence Weakened the Immune System in HIV-Positive Men
Methamphetamine use and experienced intimate partner violence led to increased HIV viral replication in Black and Latinx men who have sex with men.
HIV PrEP Use Among Heterosexual Adults Is Negligible, CDC Reports
Only 1 in 3 heterosexually active adults is aware of HIV PrEP, and this is even lower among Hispanic/Latinx men and women.
HIV Prevention Plan in Namibia Shows High Prevalence of Risk Factors
Study authors from the CDC found that girls in the sub-Saharan country of Namibia are at increased risk for HIV acquisition and also experience risk factors that make them eligible for HIV infection prevention programs.
Women Suffering from Lack of Uptake of Preferred HIV Medication
Even after it was confirmed safe, women living with HIV are neglecting to use the drug dolutegravir, potentially subjecting them to worse HIV treatment outcomes.
Too Many People Living with HIV Are Failing to Achieve Lasting Viral Suppression
Rates of sustained viral suppression among people living with HIV were lower than expected, especially among children and adolescents.
Implementing a Comprehensive nPEP Program Improves Medical Treatment
After the intervention, more patients were correctly prescribed nPEP and more follow-up visits were recommended.
Maternal STIs Increase the Risk of Preterm Birth
Pregnant women with sexually transmitted infections (STIs) were more likely to give birth prematurely.
Boosting Accuracy for Tuberculosis Screening in HIV Patients
Adding additional screening methods in combination with standard testing would increase diagnostic accuracy for tuberculosis infection among patients living with HIV.
The Long-Term Prognosis of PrEP
HIV Stakeholders weigh on the future of PrEP.
Trans People Inadequately Represented in HIV National Strategic Plans
A study found trans people were not substantively included in many countries’ HIV national strategic plans, despite being disproportionately impacted by HIV/AIDS.
2 Clarke Drive Cranbury, NJ 08512